Product logins

Find logins to all Clarivate products below.


Obesity Interventions – Market Insights – Europe

The European market for obesity interventions will grow through 2024, driven by increasing bariatric surgery procedure volumes—which will positively impact the unit sales of internal closure devices—and by growth in the intragastric balloon segment, because of the introduction of new products that will gain adoption.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the obesity interventions market in Europe across a 10-year period.

Most intragastric balloons continue to be implanted in patients who are willing to pay out-of-pocket for the procedure, limiting market growth.

Which countries in Europe have the highest procedure volumes and unit sales?

How will the introduction of new products impact this market?

What concerns have been expressed about swallowable balloons, such as the Obalon and the Elipse?

Several emerging devices have recently created headwinds in this market or are about to be launched.

What events have occurred and which devices have or will be impacted?

What device will likely obtain a CE mark in the near future?

What have physicians said about the POSE procedure?

 The value of the gastric band market will decline in Europe while the internal closure device market will experience growth.

How quickly is the gastric band market declining?

Which countries have the highest and lowest gastric banding procedure volumes?

What shares of the internal closure device market do Medtronic and Ethicon have in each country?

Table of contents


Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Biosurgical Agents – Market Insights – Latin America
The Latin American biosurgical agent market will grow modestly through 2034; although demand for biosurgical agents will rise—supported by favorable regional demographics, expanded indication…
Report
Biosurgical Agents – Market Insights – Japan
The Japanese biosurgical agent market is projected to demonstrate a modest growth through 2034, driven by the rising volume of surgical procedures, increasing physician awareness of the clinical…
Report
Biosurgical Agents – Market Insights – US
The biosurgical agent market in the US will experience modest growth through 2034. This growth will be fueled by rising surgical procedure volumes that require biosurgical agent and strong…